Date | Title | Description | Source |
21.12.2022 | Kite to Acquire Tmunity Therapeutics | Kite, a Santa Monica, CA-based Gilead Company (Nasdaq: GILD), acquired Tmunity Therapeutics, a Phila... | finsmes.co... |
06.01.2021 | Kite and Oxford BioTherapeutics Establish Cell Therapy Resea... | Santa Monica, Calif.; Oxford, UK; and San Jose, Calif., January 6 2021 - Kite, a Gilead Company (Nas... | alsaventur... |
15.12.2020 | Draper Signs Agreement with Kite to Accelerate Development o... | Draper signed an agreement with Kite, a Gilead Company, to accelerate development of cancer immunoth... | prweb.com/... |
01.08.2019 | Kite Pharma founder’s venture capital firm closes new $600M ... | A Form D filed with the Securities and Exchange Commission on July 15 states that the firm had sough... | medcitynew... |
25.04.2019 | Kite Pharma to expand manufacturing capacity with Maryland p... | Kite’s pipeline page lists a single TCR product candidate, KITE-718, a MAGE A3/A6-targeting therapy ... | medcitynew... |
30.05.2018 | J&J to enter Chinese CAR-T for myeloma into Phase Ib/II ... | The CAR-T was originally developed by Nanjing, China-based Legend, under the development name LCAR-B... | medcitynew... |
07.09.2017 | The inside story of how a $12 billion deal for a revolutiona... | Reuters
Cancer cells are seen on a large screen connected to a microscope at the CeBit computer fair... | businessin... |
30.08.2017 | A cancer treatment that one expert called the 'most exciting... | Reuters
Cancer cells are seen on a large screen connected to a microscope at the CeBit computer fair... | businessin... |
29.08.2017 | Here's why Gilead broke its dealmaking hiatus and splurged $... | jovan vitanovski/Shutterstock
For several years, investors of Gilead Sciences have clamored for the ... | businessin... |
28.08.2017 | Gilead just handed a revolutionary kind of cancer treatment ... | REUTERS/Suzanne Plunkett
A tray containing cancer cells sits on an optical microscope in the Nanomed... | businessin... |
28.08.2017 | Term Sheet — Monday, August 28 | DAY 1
Hi, I’m Polina Marinova, and it’s nice to formally meet you all. Although technically, we alre... | fortune.co... |
28.08.2017 | Gilead just bought a cancer immunotherapy company for $12 bi... | Reuters
Cancer cells are seen on a large screen connected to a microscope at the CeBit computer fair... | businessin... |
31.07.2017 | It’s not a competition but… Kite’s CAR-T therapy just claime... | The aim is to eventually treat 4-5,000 patients per year, starting with axi-cel, Kite CEO Arie Belld... | medcitynew... |
20.06.2017 | GE Ventures spin-out Vineti raises $13.75M for complex bioma... | It’s problems like those that led to the creation of Vineti, a cloud-based software platform for adv... | medcitynew... |
29.03.2017 | First come, first served: Novartis finalizes CAR-T applicati... | The equivalent approval application will be filed with the European Medicines Agency (EMA) later thi... | medcitynew... |
28.02.2017 | Kite scores a landmark win with promising 6-month lymphom... | Jeff Wiezorek, Kite
Kite Pharma’s closely-watched lead CAR-T turned in positive six-month resul... | endpts.com... |
12.01.2017 | Jet-setting CAR-Ts: Kite details commercialization plans at ... | Chairman and CEO Arie Belldegrun said the company plans to finalize its BLA submission with the FDA ... | medcitynew... |
08.12.2016 | Here’s 2017 biopharma sales projections, but Trump might hav... | On Wednesday, Time Magazine’s ‘Person of the Year’ Donald Trump told the publication that he didn’t ... | medcitynew... |
21.09.2016 | Cytokine storms force Mirna to shutter a trial; Artios ... | Mirna CEO Paul Lammers
A series of severe cases of cytokine release syndrome forced Austin, ... | endpts.com... |
25.07.2016 | Kite grabs a stem cell biology ‘breakthrough’ in race fo... | Looking for an edge in the race to develop blockbuster off-the-shelf cell therapies to fight c... | endpts.com... |
29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
19.03.2015 | West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko &... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Out west this week, Bay Area clinic... | xconomy.co... |
28.04.2014 | Kite Pharma Completes $50M Mezzanine Financing | Kite Pharma, Inc., a Santa Monica, CA-based clinical-stage biopharmaceutical company focused on deve... | finsmes.co... |
28.04.2014 |
Kite Pharma Scores $50M For Cancer Immunotherapy
| Santa Monica-based Kite Pharma said this morning that it has raised $50M, in a mezzanine, private fi... | socaltech.... |
29.05.2013 | Biotech partnered with NCI rounds up $20M to advance cancer ... | The process of removing T cells from a patient, genetically reprogramming them and re-injecting them... | medcitynew... |
16.05.2013 | Kite Pharma Closes $20M Series A Funding; Converts $15M | Kite Pharma Inc., a Los Angeles, CA-based clinical stage biotechnology company focused on developing... | finsmes.co... |
16.05.2013 | Kite Pharma Flys with $20M Investment |
LOS ANGELES, CA, Clinical stage biotechnology company focused on developing innovative targeted im... | vcnewsdail... |
15.05.2013 |
Kite Pharma Raises $35M
| - | socaltech.... |
15.05.2013 | Kite Pharma Completes $35 Million Series A Preferred Stock F... | - | tworiver.c... |
09.03.2012 | Kite Pharma Raises $15 Million in Initial Round | - | labusiness... |
09.03.2011 | Kite Pharma Raises $15M Financing Round | Kite Pharma, Inc., a Los Angeles, CA-based biopharmaceutical company focused on developing innovativ... | finsmes.co... |
09.03.2011 | Kite Pharma Raises $15 Million in Initial Round of Financing... | - | tworiver.c... |
09.03.2011 |
Kite Pharma Raises $15M
| Los Angeles-based Kite Pharma, a biopharmaceuticals firm developing treatments for cancer, said this... | socaltech.... |
- | Kite Pharma to expand manufacturing capacity with Maryland p... | The maker of one of the two approved CAR-T cell therapies appears to be anticipating future demand w... | medcitynew... |
- | Kite Pharma founder’s venture capital firm closes new $600M ... | A venture capital firm formed by a founder of one of the first companies to win Food and Drug Admini... | medcitynew... |
- | Jet-setting CAR-Ts: Kite details commercialization plans at ... | CAR-T immunotherapy is one of the most resource-intensive and personalized therapies in clinical tri... | medcitynew... |
- | Biotech partnered with NCI rounds up $20M to advance cancer ... | Boosted by a partnership with the National Cancer Institute and $20 million in new funding, a Califo... | medcitynew... |
- | It’s not a competition but… Kite’s CAR-T therapy just claime... | As Novartis awaits a final FDA ruling on its CAR-T therapy, Santa Monica, California-based Kite Phar... | medcitynew... |
- | GE Ventures spin-out Vineti raises $13.75M for complex bioma... | For all the complexity of CAR-T autologous transplant technology, Vineti has a simple question to as... | medcitynew... |
- | Here’s 2017 biopharma sales projections, but Trump might hav... | Now that we know who’s taking the White House, it’s a lot easier to predict the year ahead in biotec... | medcitynew... |
- | First come, first served: Novartis finalizes CAR-T applicati... | Novartis has made good on its promise to submit a biologics license application (BLA) for its lead C... | medcitynew... |
- | J&J to enter Chinese CAR-T for myeloma into Phase Ib/II ... | A Chinese CAR-T therapy that drew significant attention at last year’s American Society of Clinical ... | medcitynew... |